Myotonia and disorders of altered muscle cell membrane excitability

Veterinary Clinics of North America - Small Animal Practice

Volumn 32, Issue 1, 2002, Pages 169-187

  Vite, Charles H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DICHLOROPHENOXYACETIC ACID; 9 ANTHROIC ACID; ACETAZOLAMIDE; ANESTHETIC AGENT; ANTILIPEMIC AGENT; AROMATIC CARBOXYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; CHLORIDE CHANNEL BLOCKING AGENT; DANTROLENE; DICAMBA; DIURETIC AGENT; ETACRYNIC ACID; FENOTEROL; FLUDROCORTISONE; FUROSEMIDE; ION CHANNEL; MERSALYL; MEXILETINE; MUSCLE RELAXANT AGENT; NAFENOPIN; PHENYTOIN; POTASSIUM; POTASSIUM BROMIDE; POTASSIUM CHLORIDE; PROCAINAMIDE; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; TRIPARANOL; UNINDEXED DRUG; ZUCLOMIFENE;

AUTOSOMAL RECESSIVE DISORDER; BREED; CAT; CELL MEMBRANE DEPOLARIZATION; CELL STIMULATION; CLINICAL FEATURE; DELAYED RELEASE FORMULATION; DIET THERAPY; DISEASE EXACERBATION; DISEASE MODEL; DOG; DRUG CONTRAINDICATION; DRUG INTOXICATION; ELECTROMYOGRAPHY; EXCITATION CONTRACTION COUPLING; GENE MUTATION; GENE THERAPY; HUMAN; HYPERADRENOCORTICISM; HYPOKALEMIC PERIODIC PARALYSIS; MEDICAL ASSESSMENT; METABOLIC DISORDER; MOLECULAR GENETICS; MUSCLE EXCITATION; MUSCLE FIBER MEMBRANE CONDUCTANCE; MUSCLE FIBER MEMBRANE POTENTIAL; MYOTONIA; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; NEUROMUSCULAR FUNCTION; NONHUMAN; PARALYSIS; PARESIS; PATHOPHYSIOLOGY; REVIEW; SARCOLEMMA; SCHWARTZ JAMPEL SYNDROME; SKELETAL MUSCLE; THOMSEN DISEASE; VETERINARY MEDICINE;

CANIS FAMILIARIS; FELIS CATUS;

EID: 0036143764     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(03)00084-6     Document Type: Review

References (96)

1. On the repetitive discharge in myotonic muscle fibres
2. Myotonia in a Chow Chow
3. Molecular pathology of the skeletal muscle sodium channel
4. Myotonia
5. The pathophysiology of excitation in skeletal muscle
6. 2,4-D toxicosis: A pilot study of 2,4-dichlorophenoxyacetic acid- and dicamba-induced myotonia in experimental dogs
7. Molecular basis for decreased muscle chloride conductance in the myotonic goat
8. Prophylactic efficacy of phenytoin, acetazolamide and hydrochlorothiazide in horses with hyperkalaemic periodic paralysis
9. Increase of peroxysomal enzymes and myotonia induced by nafenopin, a hypolipidemic drug
10. 2,4-Dichlorophenoxyacetic acid poisoning in man
11. Molecualr screening for myotonia congenita in miniature schnauzers
12. Periodic muscle weakness in Burmese kittens
13. Pediatric myopathies
14. Experimental investigation of glucocorticoid-induced myopathy in the dog
15. Subclinical myopathy associated with hyperadrenocorticism in the dog
16. Chemically induced myotonia in amphibia
17. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3-prime end of a transcript encoding a protein kinase family member
18. Congenital myotonia in the goat
19. Muscle weakness after rest in myotonic disorders: An electrophysiological study
20. Abnormal repetitive impulse production in myotonic muscle
21. Cable properties of external intercostal muscle fibres from myotonic and nonmyotonic goats
22. Chloride conductance in normal and myotonic muscle fibres and the action of monocarboxylic aromatic acids
23. A novel sodium channel mutation in a family with hypokalemic periodic paralysis
24. A sodium channel defect in hyperkalemic periodic paralysis: Potassium induced failure of inactivation
25. A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice
26. Episodic weakness caused by hyperkalemic periodic paralysis in horses
27. Myotonia induced by clofibrate and sodium chlorophenoxy isobutyrate
28. Myotonia in canine Cushing's disease
29. Hypokalemic polymyopathy in Burmese cats
30. Pore-forming segments in voltage-gated chloride channels
31. Subunit stoichiometry of human muscle chloride channels
32. Hereditary myotonia in the Chow Chow
33. Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene
34. Excitable tissue: Nerve
35. Molecular genetics of ion channel disease
36. Dental and craniofacial findings in eight miniature schnauzer dogs affected by myotonia congenita: Preliminary results
37. Myopathy associated with hyperadrenocorticism in the dog
38. Myotonia in the dog: A report of four cases
39. Myotonic dystrophy
40. Suspected herbicide toxicosis in a dog
41. Congenital myotonia in related kittens
42. Myotonia in a Cocker Spaniel
43. Sodium channelopathies: Dramatic diseases caused by subtle genetic changes
44. Overexcited or inactive: Ion channels in muscle disease
45. Myotonia in the Great Dane
46. Myopathy associated with hyperadrenocorticism in a dog: A case report
47. Channelopathies: Episodic disorders of the nervous system
48. Hyperkalemic periodic paralysis in a dog
49. Hereditary myotonia in the Chow Chow
50. Hypokalemic myopathy in cats
51. Hypokalemic myopathy in Burmese kittens
52. Myotonia in related Chow Chow dogs
53. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current
54. Types of abnormalities
55. Tight linkage of recessive and dominant forms of human myotonia to skeletal muscle chloride channel gene
56. A muscle disorder of Labrador retrievers characterized by deficiency of type II fibers
57. Drug-induced myotonia in human intercostal muscle
58. Treatment of myotonia with antiarrhythmic drugs
59. The periodic paralyses and paramyotonia congenita
60. A hereditary disease in Burmese cats manifested as an episodic weakness with head nodding and neck ventroflexion
61. Adverse effects of drugs on muscle
62. Opisthotonus, tetanus, myoclonus, tetany, tremor, and other localized muscle spasms and movement disorders
63. Autosomal recessive myotonia congenita in sheep
64. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)
65. Characteristics of the chloride conductance in muscle fibers of the rat diaphragm
66. On the inhibition of the muscle membrane chloride conductance by aromatic carboxylic acids
67. Diazocholeterol myotonia: Accumulation of desmosterol and increased ATPase activity of sarcolemma
68. Myotonia in two aged poodles
69. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis
70. Linkage of atypical myotonia congenita to a sodium channel locus
71. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus
72. Progressive myotonia in foals resembling human dystrophia myotonica
73. A missense mutation in canine CIC-1 causes recessive myotonia congenita in the dogs
74. Experimental myotonia in mammalian skeletal muscle, changes in membrane properties
75. Altered excitability of the muscle membrane: The nondystrophic myotonias
76. Transient weakness and altered membrane characteristic in recessive generalized myotonia (Becker)
77. Linkage of hyperkalemic periodic paralysis in quarter horses to the horse adult skeletal muscle sodium channel gene
78. Periodic paralysis in quarter horses: A sodium channel mutation disseminated by selective breeding
79. The muscular dystrophies
80. Myotonia in a Staffordshire terrier
81. Myotonia congenita in a Chow Chow pup
82. Myotonic dystrophy-like disease in a dog
83. Possible adult onset myotonic dystrophy in a Boxer
84. Hyperkalemic periodic paralysis in horses
85. Myotonia in a horse
86. Inactivation of muscle chloride channel by transposon insertion in myotonic mice
87. Neuromuscular effects of acute 2,4-dichlororphenoxyacetic acid (2,4-D) exposure in dogs
88. Myotonic syndromes
89. Myotonia associated with hyperadrenocorticism in two dogs
90. Congenital myotonia in 2 domestic cats
91. Congenital myotonic myopathy in the miniature Schnauzer: An autosomal recessive trait
92. Myotonic myopathy in a miniature schnauzer: Case report and data suggesting abnormal chloride conductance across the muscle membrane
93. Three cases of myotonia in a family of Chows
94. Myopathy in an Irish Terrier with a metabolic defect of the isolated mitochondria
95. Induced myotonia in man and goat
96. Myotonic response induced by inhibitors of cholesterol biosynthesis